| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |